| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.21 | 0.0005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |